Document Detail

Sibutramine in clinical practice.
MedLine Citation:
PMID:  11916099     Owner:  NLM     Status:  MEDLINE    
The role of sibutramine as an effective adjunct to diet and exercise in weight management programmes has been proven in clinical trials. Although the reality of managing obesity in clinical practice is very different from that of a controlled clinical trial, there is good evidence that sibutramine is an easy-to-use and highly effective additional therapy when used in everyday practice to manage obesity and its complications. It is possible to predict which patients will respond well to sibutramine treatment, and to modify programmes and support to ensure the best outcome for patients, whatever their clinical circumstances.
N Finer
Related Documents :
15679789 - The role of urinary urgency and its measurement in the overactive bladder symptom syndr...
22156569 - An assessment of workplace programmes designed to control inhalation risks using respir...
22453049 - Tracking family medicine graduates. where do they go, what services do they provide and...
22192159 - Obesity management and continuing medical education in primary care: results of a swiss...
19463649 - Thymomas: review of current clinical practice.
6979419 - Appropriate uses of human immunoglobulin in clinical practice: memorandum from an iuis/...
12502289 - Manager's reports of variation in coding accuracy across u.s. oncology centers.
25272609 - The shipwreck of the singular.
22353709 - Identification of medicinal vines by its2 using complementary discrimination methods.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity     Volume:  25 Suppl 4     ISSN:  -     ISO Abbreviation:  Int. J. Obes. Relat. Metab. Disord.     Publication Date:  2001 Dec 
Date Detail:
Created Date:  2002-03-27     Completed Date:  2002-05-22     Revised Date:  2014-06-03    
Medline Journal Info:
Nlm Unique ID:  9313169     Medline TA:  Int J Obes Relat Metab Disord     Country:  England    
Other Details:
Languages:  eng     Pagination:  S12-5     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Appetite Depressants / therapeutic use*
Clinical Trials as Topic
Cyclobutanes / therapeutic use*
Obesity / prevention & control*
Physician's Practice Patterns
Product Surveillance, Postmarketing
United States
Reg. No./Substance:
0/Appetite Depressants; 0/Cyclobutanes; WV5EC51866/sibutramine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Adipocyte hypertrophy in stromelysin-3 deficient mice with nutritionally induced obesity.
Next Document:  Developing an action plan for obesity education.